Welcome to the website of
Gary B. Kaplan, M.D., Professor of Psychiatry and Pharmacology & Experimental Therapeutics and to the Kaplan Lab. The goal of our research is to better understand the neurobiology of Posttraumatic Stress Disorder, Brain Injury, and Addiction.
Our lab utilizes state-of-the-art methods in behavioral neuroscience, neuroanatomy, and neurochemistry.
Experimental Therapeutics Boston University School of Medicine
Director of Mental Health Service
VA Boston Healthcare System
150 South Huntington Avenue
Boston, MA 02130
1. Kaplan GB, Leite-Morris KA, L Wang, Rumbika KK, Heinrichs SC, Zeng X, Wu L, Arena DT, Teng YD. Pathophysiological Bases of Comorbidity: TBI and PTSD. J Neurotrauma, 2017 Oct 10. doi: 10.1089/neu.2016.4953. [Epub ahead of print] PMID: 29017388
2. Kobrin KL, Arena DT, Heinrichs SC, Kaplan GB. Dopamine D1 receptor agonist treatment attenuates extinction of morphine conditioned place preference and increases accumbal core dendritic complexity during extinction training. Behavioural Brain Research, 322 (2017) 18–28, 2017. PMID: 28089852
3. Kobrin KL, Moody O, Arena DT, Moore CF, Heinrichs SC, Kaplan GB. Acquisition of morphine conditioned place preference increases the dendritic complexity of nucleus accumbens core neurons. Addiction Biology 21:1086-1096, 2016. PMID: 26096355